Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victorhy (Topical Tiotropium) in Severe Hand Hyperhidrosis
NCT06645509Phase 2Terminated
- Sponsor
- Dryox Health
- Start
- Apr 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of TTB gel in palmar hyperhidrosis (PH) (3 arms), sponsored by Dryox Health. Primary endpoints: Mean absolute change in gravimetrically measured sweat production at Day 29 and Mean change in Hyperhidrosis Disease Severity Scale at Day 29. Started Apr 2024; status: terminated.
02
Drugs
TTB gel
03
Conditions
palmar hyperhidrosis (PH)
Beyond the preview
Go deeper on NCT06645509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06645509.